-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Scinai Immunotherapeutics Ltd. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2022 to Q2 2023.
- Scinai Immunotherapeutics Ltd. Nonoperating Income (Expense) for the quarter ending June 30, 2023 was -$1.17M, a 517% decline year-over-year.
- Scinai Immunotherapeutics Ltd. annual Nonoperating Income (Expense) for 2022 was $5.27M, a 98.2% increase from 2021.
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)